Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_assertion type Assertion NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_head.
- NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_assertion description "[ABCB1, TOP2A, ERBB2, and BCL2 were good candidates for future clinical trials of predictive chemosensitivity tests in patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_provenance.
- NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_assertion evidence source_evidence_literature NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_provenance.
- NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_assertion SIO_000772 19390941 NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_provenance.
- NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_assertion wasDerivedFrom befree-2016 NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_provenance.
- NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_assertion wasGeneratedBy ECO_0000203 NP734464.RA_OYMAV08rcjtCRvHmTzIm7NFEtcONZYdLP4cMTC2kP4130_provenance.